CLEVELAND, April 23, 2013 /PRNewswire/
-- DATATRAK International, Inc. (OTCQX: DTRK), a
leader in developing cloud-based, unified eClinical® technologies
and delivering related services for the clinical trials industry,
today announced an Israeli biopharmaceutical company chose to
standardize on the DATATRAK ONE™ clinical research
platform for its oncology program. Understanding the benefit of the
unified platform, they will utilize multiple products and modules
within the software suite – uEDC, including medical coding and
uIRT, including both Randomization and Clinical Supplies Management
– to reduce the cost of their clinical trials.
(Logo:
http://photos.prnewswire.com/prnh/20130107/CL38347LOGO)
"Our new client has an exciting history of developing novel
immunotherapy drug products," stated Laurence P. Birch, DATATRAK's
Chairman of the Board and CEO. "Pairing our expansive technology
with their innovative approach to drug development, we are able to
reduce costs across their oncology drug program as well as
accelerate their clinical trial timelines."
DATATRAK ONE™:
The DATATRAK ONE™ Clinical Research Platform is an
easy to use, cloud-based clinical enterprise solution that empowers
Sponsors and CROs to efficiently design, deliver and manage
clinical trials. From strategy and planning to resource
management and study execution needs, clients manage their entire
product portfolio in a single system with one username and
password. DATATRAK's unified clinical
enterprise solution consists of seven products: uCTMS, uDesign,
uEDC, uIRT, uSafety, uTrain and uCDR.
Join DATATRAK Thought Leaders:
LinkedIn
SlideShare
The DATATRAK Blog
Facebook
- Tweet: New Israeli Client Selects DATATRAK ONE™
for Oncology Program http://ow.ly/kjkmv
About DATATRAK International,
Inc.
DATATRAK International is a worldwide technology and
services company delivering unified eClinical™ solutions and
related services for the clinical trials industry.
DATATRAK built its multi-component, comprehensive
solution on a single, unified platform and expanded this concept to
include services delivery via DATATRAK's Clinical and
Consulting Services™ group. The Company delivers a complete
portfolio of software products designed to accelerate the reporting
of clinical research data from sites to sponsors and ultimately
regulatory authorities, faster and more efficiently than loosely
integrated technologies. The DATATRAK ONE™ software
solution, deployed worldwide through an ASP or Enterprise Transfer
offering, supports Phase I – Phase IV drug and device studies in
multiple languages throughout the world. DATATRAK has
offices located in Cleveland,
Ohio; Bryan, Texas; and
Cary (RTP), North Carolina. For
more information, visit http://www.datatrak.net.
All contracts are subject to possible delays or cancellation or
can change in scope in a positive or negative direction. Therefore,
current backlog is not necessarily indicative of the Company's
future quarterly or annual revenue. Historically, backlog has been
a poor predictor of the Company's short-term revenue.
Except for the historical information contained in this press
release, the statements made in this release are forward-looking
statements. These forward-looking statements are made based on
management's expectations, assumptions, estimates and current
beliefs concerning the operations, future results and prospects of
the Company and are subject to uncertainties and factors which are
difficult to predict and, in many instances, are beyond the control
of the Company, and which could cause actual results to differ
materially from those contemplated in these forward-looking
statements. For a list of certain factors that may cause actual
results to differ materially from those contemplated in these
forward looking statements, please see the Company's report filed
with the OTCQX Market on March 15,
2013 announcing its results for the fourth quarter and full
year of 2012. The Company undertakes no obligation to update
publicly or revise any forward-looking statement whether as a
result of new information, future events or otherwise.
SOURCE DATATRAK International, Inc.
